Overview

Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine

Status:
Terminated
Trial end date:
2018-08-06
Target enrollment:
Participant gender:
Summary
The study is a 6-week, proof-of-concept, open trial of vortioxetine for 20 patients with major depressive disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Takeda
Treatments:
Vortioxetine